Pharmacy in Focus: Unlocking the promise of biosimilars

In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.

July 30, 25

Specialty pipeline perspectives: The upcoming wave of biosimilars

Evernorth anticipates a dramatic shift in inflammatory and oncology treatments over the next five years, with dozens of biosimilars in the pipeline.

March 26, 25

Biosimilars help lower costs and foster innovation in pharmacy benefits

By creating competition that can significantly reduce the prices of biologic medications, biosimilars create financial headroom for plan sponsors to offer coverage for innovative drug treatments.

September 30, 24

Express Scripts continues efforts to lower drug costs and ensure streamlined patient access to innovative biosimilars

August 23, 24

Evernorth chief bullish on driving affordability through biosimilars and access through guided care

May 08, 24